Effectiveness of COVID-19 vaccines against laboratory-confirmed SARS-CoV-2 infection amongst health workers, Windhoek, Namibia
The VE results suggest that COVID-19 vaccines used in Namibia provided good protection from infections with the Omicron variant even if many participants had a SARS-CoV-2 infection before the study. Therefore, COVID-19 vaccines should be administered to risk groups such as HWs independent from previous infections.
Authors
- Christian Winter (ORCID: https://orcid.org/0000-0001-6327-0209)
- Emmanuel Nepolo (ORCID: https://orcid.org/0000-0003-4302-5606)
- Ismael Katjitae
- Kaveto Sikuvi
- Natasha Nghitukwa
- Carolina Matos
- Ndiitodino Kakehongo
- Philip Oedi
- Sibongile Manga Netha
Institutions
- University of Namibia (NA)
- Robert Koch Institute (DE)
- Ministry of Health and Social Services (NA)
Publication Details
- Journal
- Vaccine
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.vaccine.2025.126977
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- World Health Organization